$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Conjugates for use in hepatocyte free uptake assays 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/70
출원번호 US-0221001 (2005-09-07)
등록번호 US7884086 (2011-01-26)
발명자 / 주소
  • Bennett, C. Frank
  • McKay, Robert
  • Monia, Brett P.
  • Baker, Brenda F.
  • Sioufi, Namir
출원인 / 주소
  • Isis Pharmaceuticals, Inc.
대리인 / 주소
    Isis Patent Department Woodcock Washburn LLP
인용정보 피인용 횟수 : 15  인용 특허 : 399

초록

The present invention provides methods of identifying oligomeric compounds, such as siRNA and double-stranded RNA compounds, having bioactivity in vivo, and kits.

대표청구항

What is claimed is: 1. A method for reducing the level of target mRNA in a cell comprising:contacting the cell with a single-stranded sense oligonucleotide consisting of 10 to 40 linked nucleosides; andcontacting the cell with a single-stranded antisense oligonucleotide consisting of 10 to 40 linked

이 특허에 인용된 특허 (399)

  1. Tkachuk Zenovy (Kiev SUX) Kvasyuk Eugeny (Kiev SUX) Matsuka Gennady (Kiev SUX) Mikhailopulo Igor (Kiev SUX), (2′-5′) oligoadenylate analogues useful as inhibitors of host-v5.-graft response.
  2. De Clercq Erik D. A. (Lovenjoel BEX) Herdewijn Piet A. M. (Rotselaar BEX) Van Aerschot Arthur A. E. (Heist o/d Berg BEX), 1,5-anhydrohexitol nucleoside analogues.
  3. Beigelman, Leonid; Karpeisky, Alex, 2′-O-alkylthioalkyl and 2′-C-alkylthioalkyl-containing nucleic acids.
  4. Buhr Chris A. ; Matteucci Mark, 2' Modified Oligonucleotides.
  5. Chris A. Buhr ; Mark Matteucci, 2' Modified oligonucleotides.
  6. Manoharan Muthiah ; Cook Phillip Dan, 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides.
  7. Manoharan Muthiah ; Kawasaki Andrew M. ; Cook Phillip Dan ; Fraser Allister S. ; Prakash Thazha P., 2'-O-acetamido modified monomers and oligomers.
  8. Beigelman Leonid ; Karpeisky Alex, 2'-O-alkylthioalkyl and 2'-C-alkylthioalkyl-containing nucleic acids.
  9. Beigelman Leonid ; Karpeisky Alex, 2'-O-alkylthioalkyl and 2'-c-alkylthioalkyl-containing nucleic acids.
  10. Beigelman Leonid ; Karpeisky Alex, 2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes).
  11. Cook Phillip Dan ; Manoharan Muthiah ; Kawasaki Andrew Mamoru, 2'-O-aminooxy-modified oligonucleotides.
  12. Cook Phillip Dan ; Guinosso Charles John, 2'-O-modified nucleosides and phosphoramidites.
  13. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-O-modified oligonucleotides.
  14. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  15. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  16. Cook, Phillip Dan; Kawasaki, Andrew Mamoru, 2'modified oligonucleotides.
  17. Huynh Dinh Tam (Croissy/Seine FRX) Gouyette Catherine (Vanves FRX) Igolen Jean (Le Mesnil St. Denis FRX), 2,N6-disubstituted and 2,N6-trisubstituted adenosine-3′-phosphoramidites.
  18. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), 2,′,5′-phosphorothioate oligoadenylates and plant antiviral uses thereof.
  19. Buhr Chris A. (Daly City CA) Matteucci Mark (Burlingame CA), 2\modified nucleoside and nucleotide compounds.
  20. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 2′,5′-phosphorothioate oligoadenylates and their covalent conjugates with polylysine.
  21. Sproat Brian (Heidelberg DEX) Lamond Angus (Wiesenbach DEX), 2′-O-alkylnucleotides as well as polymers which contain such nucleotides.
  22. Usman Nassim (Boulder CO) Karpeisky Alexander (Boulder CO) Beigelman Leonid (Longmont CO) Modak Anil (Boulder CO), 2′-deoxy-2′alkylnucleotide containing nucleic acid.
  23. Montgomery John A. (Birmingham AL) Secrist ; III John A. (Birmingham AL), 2′-deoxy-4′-thioribonucleosides and their antiviral activity.
  24. Usman Nassim (Boulder CO) Karpeisky Alexander (Boulder CO) Beigelman Leonid (Longmont CO) Modak Anil (Boulder CO), 2′deoxy-2′-alkylnucleotide containing nucleic acid.
  25. Cook P. Dan (Carlsbad CA) Acevedo Oscar L. (San Diego CA) Andrews Robert S. (San Juan Capistrano CA), 3-deazapurines.
  26. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 3′-deoxy or 3′-O-substituted-2′,5′-oligoadenylates as antiviral agents.
  27. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), 4′-desmethyl nucleoside analog compounds.
  28. Cook Philip D. (Carlsbad CA) Delecki Daniel J. (Radnor PA) Guinosso Charles (Vista CA), Acyclic nucleoside analogs and oligonucleotide sequences containing them.
  29. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR) Stirchak Eugene P. (Corvallis OR), Alpha-morpholino ribonucleoside derivatives and polymers thereof.
  30. Bennett C. Frank ; Cooke Stanley T. ; Manoharan Muthiah ; Wyatt Jacqueline R. ; Baker Brenda F. ; Monia Brett P. ; Freier Susan M. ; McKay Robert ; Karras James G., Alteration of cellular behavior by antisense modulation of mRNA processing.
  31. Fung Steven (Palo Alto CA) Woo Sam L. (Redwood City CA) Smith Lloyd M. (South Pasadena CA), Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof.
  32. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphorothioamidate oligonucleotide deratives.
  33. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphotriester oligonucleotide derivatives.
  34. Manoharan Muthiah ; Cook Phillip Dan ; Prakash Thazha P. ; Kawasaki Andrew M., Aminooxy-modified oligonucleotides and methods for making same.
  35. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Anthraquinone-derivatives oligonucleotides.
  36. Monia Brett P. ; Cowsert Lex M., Antisense inhibition of MAP kinase kinase 6 expression.
  37. Monia Brett P. ; Gaarde William ; Ward Donna T. ; Freier Susan M. ; Wyatt Jacqueline, Antisense inhibition of MEKK2 expression.
  38. Monia Brett P. ; Cowsert Lex M. ; McKay Robert, Antisense inhibition of PTEN expression.
  39. Bennett C. Frank ; Dean Nicholas M. ; Monia Brett P. ; Nickoloff Brian J. ; Zhang QingQing, Antisense modulation of BCL-X expression.
  40. Bennett C. Frank ; Condon Thomas P. ; Flournoy Shin Cheng ; Zhang Hong, Antisense modulation of PECAM-1.
  41. C. Frank Bennett ; Lex M. Cowsert, Antisense modulation of calreticulin expression.
  42. Goodnow ; Jr. Robert Alan ; Tam Steve Yik-Kai, Antisense oligomers.
  43. McKay Robert ; Dean Nicholas ; Monia Brett P. ; Nero Pamela S. ; Gaarde William A., Antisense oligonucleotide compositions and methods for the modulation of JNK proteins.
  44. Baracchini Edgardo ; Bennett C. Frank ; Dean Nicholas M., Antisense oligonucleotide modulation of multidrug resistance-associated protein.
  45. Switzer Christopher (Moreno Valley CA), Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides.
  46. McCormick Randy M. (Wilmington DE), Arabinonucleic acid probes for DNA/RNA assays.
  47. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  48. De Mesmaeker Alain (Kaenerkinden CHX) Lebreton Jacques (Marseilles FRX) Waldner Adrian (Allschwil CHX) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  49. Sanghvi Yogesh S. ; Cook Phillip Dan, Backbone modified oligonucleotide analogs and preparation thereof through radical coupling.
  50. Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling.
  51. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Morvan Francois (Montpellier FRX), Backbone modified oligonucleotide analogs and solid phase synthesis thereof.
  52. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  53. Cook Phillip Dan ; Sanghvi Yogesh Shantilal ; Vasseur Jean Jacques ; Debart Francoise, Backbone modified oligonucleotide analogues.
  54. Sanghvi Yogesh S. (San Marcos CA) Cook Phillip D. (Vista CA), Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling.
  55. Suhadolnik Robert J. ; Pfleiderer Wolfgang,DEX, Base-modified derivatives of 2',5'-oligoadenylate and antiviral uses thereof.
  56. Usman Nassim ; Beigelman Leonid ; McSwiggen James ; Karpeisky Alex, Base-modified enzymatic nucleic acid.
  57. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  58. Leumann Christian (Zurich CHX), Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates.
  59. Imanishi Takeshi,JPX ; Obika Satoshi,JPX, Bicyclonucleoside and oligonucleotide analogues.
  60. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  61. Tomalia Donald A. ; Baker James R. ; Cheng Roberta C. ; Bielinska Anna U. ; Fazio Michael J. ; Hedstrand David M. ; Johnson Jennifer A. ; Kaplan ; deceased Donald A. ; Klakamp Scott L. ; Kruper ; Jr., Bioactive and/or targeted dendrimer conjugates.
  62. Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Brookline MA) Langer Robert S. (Newton MA), Biodegradable injectable nanoparticles.
  63. Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same.
  64. Spielvogel Bernard F. (107 Wood Glen Dr. Cary NC 27511) Sood Anup (5041 Gatewood Dr. Durham NC 27712), Boronated phosphoramidate compounds.
  65. Hogan James J. (Coronado CA) Arnold ; Jr. Lyle J. (San Diego CA) Nelson Norman C. (San Diego CA) Bezverkov Robert (Cardiff by the Sea CA), Branched nucleic acid probes.
  66. Chung Thomas D. Y. ; Cianci Christopher W. ; Hagen Moira ; Krystal Mark ; Colonno Richard J., Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease.
  67. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  68. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  69. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  70. Altmann Karl-Heinz (Basel CHX) Imwinkelried Rene (Brig-Glis CHX) Eschenmoser Albert (Kusnacht CHX), Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use.
  71. Manoharan Muthiah, Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages.
  72. Manoharan Muthiah, Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages.
  73. Felgner Philip L. (Rancho Santa Fe CA) Kumar Raj (San Diego CA) Basava Channa (San Diego CA) Border Richard C. (Poway CA) Hwang-Felgner Jiin-Yu (Rancho Santa Fe CA), Cationic lipids for intracellular delivery of biologically active molecules.
  74. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Cholesterol conjugates of 2′5′-oligoadenylate derivatives and antiviral uses thereof.
  75. Letsinger Robert L. (Wilmette IL), Cholesteryl modified oligonucleotides.
  76. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent (Austin TX), Chromophore probe for detection of nucleic acid.
  77. Bertsch-Frank Birgit (Rheinfelden DEX) Klasen Claas-Juergen (Freigericht DEX) Lieser Thomas (Hapau DEX) Mueller Klaus (Hasselroth DEX) Bewersdorf Martin (Gelnhausen DEX), Coated sodium percarbonate particles, a process for their production and detergent, cleaning and bleaching compositions.
  78. Curiel David T. (Chapel Hill NC) Birnstiel Max L. (Vienna ATX) Cotten Matthew (Vienna ATX) Wagner Ernst (Langenzersdorf ATX) Zatloukal Kurt (Vienna ATX) Plank Christian (Vienna ATX) Oberhauser Berndt, Composition for introducing nucleic acid complexes into higher eucaryotic cells.
  79. Snitman David L. (Boulder CO), Compositions and methods for functionalizing nucleic acids.
  80. Phillip Dan Cook ; Thomas Bruice ; Charles John Guinosso ; Andrew Mamoru Kawasaki ; Richard Griffey, Compositions and methods for modulating RNA.
  81. Teng, Ching-Leou; Hardee, Greg, Compositions and methods for the delivery of oligonucleotides via the alimentary canal.
  82. Stec Wojciech J.,PLX ; Wozniak Lucyna,PLX, Compositions and methods for the synthesis of organophosphorus derivatives.
  83. Cook Phillip D. (Carlsbad CA) Bruice Thomas (Carlsbad CA) Guinosso Charles J. (Carlsbad CA) Kawasaki Andrew M. (Oceanside CA), Compositions for inhibiting RNA activity.
  84. Cook Phillip Dan ; Ecker David J. ; Guinosso Charles John ; Acevedo Oscar Leobardo ; Kawasaki Andrew ; Ramasamy Kandasamy, Compound for detecting and modulating RNA activity and gene expression.
  85. Kmiec Eric B. (Malvern PA), Compounds and methods for site directed mutations in eukaryotic cells.
  86. Ohtsuka Eiko (Sappro JPX) Inoue Hideo (Sappro JPX) Morisawa Hirokazu (Kawasaki JPX) Shibahara Susumu (Kawasaki JPX) Mukai Sachiko (Kawasaki JPX) Nishihara Tohru (Kurashiki JPX), Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and st.
  87. Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Compounds having phosphorodithioate linkages of high chiral purity.
  88. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  89. Dange Veerapanani ; Iwao Nozawa JP, Conjugates and methods of forming conjugates of oligonucleotides and carbohydrates.
  90. Curiel David T. (Chapel Hill NC) Hu Ping-chuan (Chapel Hill NC) Birnstiel Max L. (Vienna ATX) Cotten Matthew (Vienna ATX) Wagner Ernst (Langenzersdorf ATX), Conjugates for introducing nucleic acid into higher eucaryotic cells.
  91. Dellinger Douglas J. (Cardiff by the Sea CA), Copolymers of N-vinyl-lactams suitable for oligomer solid phase synthesis.
  92. Saba Don (Tucson AZ) Glass Richard S. (Tucson AZ) Yabusaki Kenichi K. (Albany CA), Coumarin derivatives for use as nucleotide crosslinking reagents.
  93. Linn C. Preston (Durham NC) Pitner J. Bruce (Durham NC) Mize Pat D. (Durham NC), Covalent cyanine dye oligonucleotide conjugates.
  94. Cook Phillip Dan ; Manoharan Muthiah ; Bruice Thomas, Covalently cross-linked oligonucleotides.
  95. Igor V. Kutyavin ; Eugeny A. Lukhtanov ; Howard B. Gamper ; Rich B. Meyer, Jr., Covalently linked oligonucleotide minor groove binder conjugates.
  96. Cook Phillip D. (Carlsbad CA) Baschang Gerhard (Bettingen CHX), Cyclobutyl oligonucleotide surrogates.
  97. Cook Phillip Dan ; Baschang Gerhard,CHX, Cyclobutyl oligonucleotide surrogates.
  98. Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA) Kaiser ; Jr. Robert J. (Glendale CA), DNA-reporter conjugates linked via the 2′or 5′-primary amino group of the 5′-terminal nucleoside.
  99. Nilsen Thor W., Dendritic nucleic acids exhibiting maximal self-assembly.
  100. Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA), Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for t.
  101. Usman Nassim ; Wincott Francine E. ; Tracz Danuta, Deprotection of RNA with alkylamine.
  102. Manoharan Muthiah ; Cook Phillip Dan ; Bennett Clarence Frank, Derivatized oligonucleotides having improved uptake and other properties.
  103. Muthiah Manoharan ; Phillip Dan Cook ; Clarence Frank Bennett, Derivatized oligonucleotides having improved uptake and other properties.
  104. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) De Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel C, Dinucleoside phosphinates and their pharmaceutical compositions.
  105. Tagawa Toshiaki (Yokohama JPX) Hosokawa Saiko (Kawasaki JPX) Nagaike Kazuhiro (Sagamihara JPX), Drug-containing protein-bonded liposome.
  106. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), Dual action 2′,5′-oligoadenylate antiviral derivatives and uses thereof.
  107. Wurster Robert L., Dual ended laser swing aid.
  108. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Encapsulated 2′,5′-phosphorothioate oligoadenylates.
  109. Sullivan Sean M. (Pasadena CA), Encapsulation process.
  110. Brakel Christine L. (Brightwaters NY) Cook Alan F. (Cedar Groove NJ) Vuocolo Edmund (Bronx NY), End labeled nucleotide probe.
  111. Froehler Brian (Belmont CA) Matteucci Mark (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified purines.
  112. Froehler Brian (Belmont CA) Wagner Rick (Belmont CA) Matteucci Mark (Burlingame CA) Jones Robert J. (Millbrae CA) Gutierrez Arnold J. (Sandy Lane CA) Pudlo Jeff (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  113. Goodchild John, Enhancement of ribozyme catalytic activity by A 2'-O-substituted facilitator oligonucleotide.
  114. Goodchild John (Worcester MA), Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide.
  115. Uhlmann Eugen,DEX ; Engels Joachim,DEX ; Scherr Michaela,DEX ; Ganser Arnold,DEX, Enzymatic RNA molecules that cleave mutant N-RAS.
  116. Matulic-Adamic Jasenka ; Beigelman Leonid ; Karpeisky Alexander ; Jarvis Thale ; Usman Nassim ; DiRenzo Anthony ; Wincott Francine, Enzymatic nucleic acids containing 5'-and/or 3'-cap structures.
  117. Ingram Lonnie O. (Gainesville FL) Conway Tyrrell (Lincoln NE) Alterthum Flavio (Gainesville FL), Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes.
  118. Weis Alexander L. (Berwyn PA) Oakes Fred T. (Rochester NY) Hausheer Frederick H. (San Antonio TX) Cavanaugh ; Jr. Paul F. (West Chester PA) Moskwa Patricia S. (Phoenixville PA), Exonuclease resistant terminally substituted oligonucleotides.
  119. Froehler Brian C. (Belmont CA), Exonuclease-resistant oligonucleotides.
  120. Brush Charles K. (Whitefish Bay WI), Fluorescein labelled phosphoramidites.
  121. Cook Phillip D. (Vista CA) Monia Brett P. (Carlsbad CA), Gapped 2′modified oligonucleotides.
  122. Fire, Andrew; Kostas, Stephen; Montgomery, Mary; Timmons, Lisa; Xu, SiQun; Tabara, Hiroaki; Driver, Samuel E.; Mello, Craig C., Genetic inhibition by double-stranded RNA.
  123. Bayer Ernst (Bei der Ochsenweide D-7400 Tubingen DEX) Rapp Wolfgang (Stuttgart DEX), Graft copolymers of crosslinked polymers and polyoxyethylene, processes for their production, and their usage.
  124. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized nucleotides and precursors thereof.
  125. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized oligonucleotides and method/synthesis.
  126. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Heteroatomic oligonucleoside linkages.
  127. Cook Phillip Dan ; Sanghvi Yogesh Shantilal, Heteroatomic oligonucleoside linkages.
  128. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  129. Schally Andrew V. ; Izdebski Jan, Highly potent agonists of growth hormone releasing hormone.
  130. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  131. Metelev, Valeri; Agrawal, Sudhir, Hybrid oligonucleotide phosphorothioates.
  132. Froehler Brian C. (Belmont CA) Buhr Chris A. (Daly City CA), Hydrogen phosphonodithioate compositions.
  133. Krieg Arthur M. ; Kline Joel ; Klinman Dennis ; Steinberg Alfred D., Immunostimulatory nucleic acid molecules.
  134. Rogers Thomas E. (Manchester MO) Gray Steven H. (Ellisville MO) Devadas Balekudru (Chesterfield MO) Adams Steven P. (St. Charles MO), Improved probes using nucleosides containing 3-dezauracil analogs.
  135. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  136. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  137. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  138. Hoffman Allan S. ; Stayton Patrick S., Interactive molecular conjugates.
  139. Coassin Peter J. (San Juan Capistrano CA) Konrad Kenneth D. (Long Beach CA) Rampal Jang B. (Yorba Linda CA) Cook Ronald M. (San Rafael CA), Inverse linkage oligonucleotides for chemical and enzymatic processes.
  140. Agrawal Sudhir (Shrewsbury MA), Inverted chimeric and hybrid oligonucleotides.
  141. Donald L. Wollesen, Junction profiling using a scanning voltage micrograph.
  142. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Linear aminoalkylphosphoramidate oligonucleotide derivatives.
  143. Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Linkage of proteins to nucleic acids.
  144. Arnold ; Jr. Lyle J. (San Diego CA) Reynolds Mark A. (San Diego CA) Bhatt Ram S. (San Diego CA), Linking reagents for nucleotide probes.
  145. Zalipsky Samuel (Fremont CA) Woodle Martin C. (Menlo Park CA) Lasic Danilo D. (Newark CA) Martin Francis J. (San Francisco CA), Lipid-polymer conjugates and liposomes.
  146. Louis C. Smith ; James T. Sparrow ; Jochen Hauer ; Martha P. Mims, Lipophilic peptides for macromolecule delivery.
  147. Tari Ana Maria (Houston TX) Lopez-Berestein Gabriel (Houston TX) Deisseroth Albert B. (Houston TX), Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use.
  148. Bally Marcel B. (Bowen Island CAX) Boman Nancy L. (Richmond CAX) Cullis Pieter R. (Vancouver CAX) Mayer Lawrence D. (North Vancouver CAX), Liposomal compositions for enhanced retention of bioactive agents.
  149. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  150. Langel Ulo,SEX ; Bartfai Tamas,CHX ; Pooga Margus,EEX ; Valkna Andres,EEX ; Saar Kulliki,SEX ; Hallbrink Mattias,SEX, Membrane-permeable constructs for transport across a lipid membrane.
  151. Thomas H. Adams ; Mark A. Reynolds, Metal complex containing oligonucleoside cleavage compounds and therapies.
  152. Low Philip S. (West Lafayette IN) Horn Mark A. (West Lafayette IN) Heinstein Peter F. (West Lafayette IN), Method for enhanced transmembrane transport of exogenous molecules.
  153. Low Philip S. (West Lafayette IN) Horn Mark A. (West Lafayette IN) Heinstein Peter F. (West Lafayette IN), Method for enhancing transmembrane transport of exogenous molecules.
  154. Benner Steven A. (Hadlaubstrasse 151 CH-8006 Zurich CHX), Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases.
  155. Arnold ; Jr. Lyle J. ; Reynolds Mark A. ; Giachetti Cristina, Method for inhibiting RNA translation using chimeric oligonucleoside compounds.
  156. Kaji Akira (1-9 ; Daimoncho 1-chome Higashikurume-shi ; Tokyo JPX), Method for inhibiting propagation of virus and anti-viral agent.
  157. Matteucci Mark D. (Burlingame CA) Zhang Jiancun (San Francisco CA), Method for oligonucleotide analog synthesis.
  158. Torrence Paul (Silver Spring MD) Silverman Robert (Shaker Heights OH) Maitra Ratan (Euclid OH) Lesiak Krystyna (Gaithersburg MD), Method of cleaving specific strands of RNA and medical treatments thereby.
  159. Agnello Vincent, Method of detecting hepatitis C virus in tissues.
  160. Agrawal Sudhir (Shrewsbury MA) Diasio Robert B. (Birmingham AL) Zhang Ruiwen (Birmingham AL), Method of down-regulating gene expression.
  161. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent L. (Austin TX) Sansom Petra I. (Austin TX) Crofts Shaun P. (Campbell CA), Method of expanded porphyrin-oligonucleotide conjugate synthesis.
  162. Irving Edward (Burwell GB2) Banks Christopher P. (Saffron Walden GB2), Method of forming images.
  163. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  164. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  165. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  166. Stec Wojciech J. (Lodz PLX) Uznanski Bogdan (Lodz CA PLX) Bergot B. John (Redwood City CA) Hirschbein Bernard L. (San Francisco CA) Fearon Karen L. (Union City CA), Method of synethesizing sulfurized oligonucleotide analogs.
  167. Benderev Theodore V. (27748 Sommerset La. San Juan Capistrano CA 92675) Naves Neil H. (28852 Woodcreek Mission Viego CA 92692) Legome Mark J. (3255 Driza Mission Viego CA 92692), Method of tensioning a suspended tissue mass.
  168. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Huang Shi K. (Castro Valley CA), Method of treatment of inflamed tissues.
  169. Alul Rushdi (Columbia MD), Methods and compositions for sequence-specific hybridization of RNA by 2′-5′oligonucleotides.
  170. Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA) Eder Paul S. (Iowa City IA) Dagle John M. (Iowa City IA), Methods for blocking the expression of specifically targeted genes.
  171. Gururaja Turuvekere R. (North Andover MA) Adams Darwin P. (Lexington MA) Herrick Benjamin M. (Boxborough MA) Prater David M. (Melrose MA), Methods for controlling sensitivity of electrostrictive transducers.
  172. Walder Joseph A. ; Walder Roxanne Y. ; Eder Paul S. ; Dagle John M., Methods for decreasing the expression of specifically targeted genes.
  173. Muthiah Manoharan, Methods for the preparation of conjugated oligomers.
  174. Cook Phillip Dan (Vista CA) Teng Kelly (San Diego CA), Methods of making conjugated 4′desmethyl nucleoside analog compounds.
  175. Unger Evan C. (Tucson AZ) Fritz Thomas A. (Tucson AZ) Matsunaga Terry (Tucson AZ) Ramaswami VaradaRajan (Tucson AZ) Yellowhair David (Tucson AZ) Wu Guanli (Tucson AZ), Methods of preparing gas-filled liposomes.
  176. Froehler Brian ; Wagner Rick ; Matteucci Mark ; Jones Robert J. ; Gutierrez Arnold J. ; Pudlo Jeff, Methods of using oligomers containing modified pyrimidines.
  177. Daily William J. ; Schwartz David Aaron, Methylphosphonate dimer synthesis.
  178. Sundaramoorthi Swaminathan ; Mark Matteucci ; Jeff Pudlo ; Robert J. Jones, Modified internucleoside linkages (II).
  179. Swaminathan Sundaramoorthi ; Matteucci Mark ; Pudlo Jeff ; Jones Robert J., Modified internucleoside linkages (II).
  180. Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  181. Mishra Nrusingha C. (Germantown MD) Khorshidi Hossein S. (Vienna VA) Gan Yuxiang (Bethesda MD) Szweda Pam (Cleveland Heights OH) George Jay (Gaithersburg MD), Modified nucleotides for nucleic acid labeling.
  182. Pieles Uwe (Gttingen DEX) Englisch Uwe (Gttingen DEX) Cramer Friedrich (Gttingen DEX), Modified oligonucleotides.
  183. Sanghvi Yogesh S. ; Cook Phillip Dan, Modified oligonucleotides.
  184. Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  185. Seela Frank,DEX ; Thomas Horst,DEX, Modified oligonucleotides, their preparation and their use.
  186. Eckstein Fritz (Gottingen DEX) Pieken Wolfgang (Boulder CO) Benseler Fritz (Gleichen/Etzborn DEX) Olsen David B. (West Point PA) Williams David M. (Cambridge GB2) Heidenreich Olaf (Gottingen DEX), Modified ribozymes.
  187. Eckstein Fritz (Gottingen DEX) Pieken Wolfgang (Boulder CO) Benseler Fritz (Gleichen/Etzborn DEX) Olsen David B. (West Point PA) Williams David M. (Cherry Hinton GB2) Heindenreich Olaf (Gottingen DEX, Modified ribozymls.
  188. Martin ; Jr. Thomas J. (Kearny NJ), Modular valve service box.
  189. Chang Tse-wen (Houston TX) deVilliers Jean (Houston TX) Gordon Wayne (Houston TX), Molecular conjugates containing cell membrane-blending agents.
  190. Cook Phillip D. (Carlsbad CA), Monomers for preparation of oligonucleotides having chiral phosphorus linkages.
  191. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Morpholino-subunit combinatorial library and method.
  192. Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Multifunctional nucleic acid monomer.
  193. Cook P. Dan (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), N-2 substituted purines.
  194. Chang Chu-An (Piedmont CA) Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith.
  195. Chang Chu-An (Piedmont CA) Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith.
  196. Srivastava Suresh C. (Burlington MA) Roy Saroj K. (Waltham MA), N-protected-2′-O-methyl-ribonucleosides and N-protected 2′-O-methyl-3′-cyanoethyl-N-,N-diisopropyl phosphoramidite ri.
  197. Zablocki Jeff A. ; Palle Venkata P. ; Ibrahim Prabha N. ; Belardenelli Luiz, N6 heterocyclic 8-modified adenosine derivatives.
  198. Nelson Paul S. (Union City CA) Kent Mark A. (Sunnyvale CA), Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides.
  199. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods.
  200. Usman, Nassim; Wincott, Francine; Matulic-Adamic, Jasenka; Beigelman, Leonid; Karpeisky, Alex, Non-nucleotide containing RNA.
  201. Usman Nassim ; Wincott Francine ; Matulic-Adamic Jasenka ; Beigelman Leonid ; Karpeisky Alex, Non-nucleotide containing enzymatic nucleic acid.
  202. Usman Nassim ; Wincott Francine ; Matulic-Adamic Jasenka ; Beigelman Leonid ; Karpeisky Alex, Non-nucleotide containing enzymatic nucleic acid.
  203. Shizuya Hiroaki (1632 Indiana Ave. South Pasadena CA 91030) Millar Sharon L. (1825 Lanai St. West Covina CA 91792), Non-radioisotope tagging of fragments.
  204. Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  205. Tullis Richard H. (Leucadia CA), Novel amphiphilic nucleic acid conjugates.
  206. Nguyen Thanh T. (Tigy FRX) Helene Claude (Saint Cyr en Val FRX) Asseline Ulysse (La Source FRX), Novel compounds containing an oligonucleotide sequence bonded to an intercalating agent, a process for their synthesis a.
  207. Weis Alexander L. (Berwyn PA) Oakes Fred T. (Rochester NY) Hausheer Frederick H. (San Antonio TX) Cavanaugh ; Jr. Paul F. (West Chester PA) Moskwa Patricia S. (Phoenixville PA), Nuclease resistant compounds.
  208. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression.
  209. Swaminathan Sundaramoorthi ; Matteucci Mark ; Jones Robert J. ; Pudlo Jeff ; Munger John, Nuclease stable and binding competent oligomers and methods for their use.
  210. Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA), Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled.
  211. Bischofberger Norbert W. (San Carlos CA) Matteucci Mark D. (Burlingame CA), Nucleic acid intercalating agents.
  212. Thompson, James; Beigelman, Leonid; McSwiggen, James; Karpeisky, Alexander; Bellon, Laurent; Reynolds, Mark; Zwick, Michael; Jarvis, Thale; Woolf, Tod; Haeberli, Peter; Matulic-Adamic, Jasenka, Nucleic acid molecules with novel chemical compositions capable of modulating gene expression.
  213. Ramachandran Kuzhalmannam L. (Natick MA) Cate Richard L. (Plymouth MA), Nucleic acid probe linked to a label having a terminal cysteine.
  214. Rokita Steven E. (Port Jefferson NY) Chatterjee Moneesh (Stony Brook NY), Nucleic acids labeled with naphthoquinone probe.
  215. Buhr Chris (Daly City CA) Matteucci Mark (Burlingame CA) Bischofberger Norbert W. (San Carlos CA) Froehler Brian (Belmont CA), Nucleoside 5′-methylene phosphonates.
  216. Haralambidis Jim (Victoria AUX), Nucleoside derivatives.
  217. Froehler Brian C. (Belmont CA) Buhr Chris A. (Daly City CA), Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues.
  218. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel CHX), Nucleoside phosphinate compounds and compositions.
  219. Martin Pierre,CHX, Nucleosides and oligonucleotides having 2'-ether groups.
  220. Caruthers Marvin H. (Boulder CO) Matteucci Mark D. (San Francisco CA), Nucleosides useful in the preparation of polynucleotides.
  221. Andrei P. Guzaev ; Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Nucleosidic and non-nucleosidic folate conjugates.
  222. Klevan Leonard (Washington DC) Gebeyehu Gulilat (Silver Spring MD) Rao Prasad Y. (Damascus MD), Nucleotide analogs for nucleic acid labeling and detection.
  223. Imanishi Takeshi,JPX, Nucleotide analogues.
  224. Khan Shaheer H. ; Rosenblum Barnett B. ; Zhen Weiguo ; Menchen Steven M., Nucleotide compounds including a rigid linker.
  225. Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Nucleotides for introducing selectably cleavable and/or abasic sites into oligonucleotides.
  226. Meyer ; Jr. Rich B. (Woodinville WA) Adams A. David (Snohomish WA) Petrie Charles R. (Woodinville WA), Oligo (aa 상세보기
  • Muhlegger Klasu,DEX ; Von Der Eltz Herbert,DEX ; Seela Frank,DEX ; Rosemeyer Helmut,DEX, Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity.
  • Gryaznov Sergei (San Mateo CA) Schultz Ronald G. (Fremont CA), Oligo-2′-fluoronucleotide N3′->P5′phosphoramidates.
  • Gryaznov Sergei M. ; Schultz Ronald G. ; Chen Jer-Kang, Oligodeoxyribonucleotide N3' P5' phosphoramidates.
  • Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  • Arnold ; Jr. Lyle J. ; Reynolds Mark A. ; Schwartz David A. ; Daily William J., Oligonucleoside cleavage compounds and therapies.
  • Sanghvi Yogesh S. ; Cook Phillip Dan, Oligonucleoside linkages containing adjacent nitrogen atoms.
  • Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  • Hecht Sidney M. (Charlottesville VA), Oligonucleotide N-alkylphosphoramidates.
  • Gryaznov Sergei M. ; Schultz Ronald G. ; Chen Jer-kang, Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties.
  • Gryaznov Sergei M. ; Schultz Ronald G. ; Chen Jer-kang, Oligonucleotide N3'.fwdarw.P5' phosphoramidates.
  • Bischofberger Norbert (San Carlos CA) Kent Ken (Mountain View CA) Wagner Rick (Burlingame CA) Buhr Chris (Daly City CA) Lin Kuei-Ying (Fremont CA), Oligonucleotide analogs capable of passive cell membrane permeation.
  • Benner Steven A. (Grossmannstrasse 16 ; #7 CH-8049 Zurich CHX), Oligonucleotide analogs containing sulfur linkages.
  • Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Oligonucleotide analogs having modified dimers.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Huie Edward M. (Wilmington DE) Trainor George L. (Wilmington DE), Oligonucleotide analogs with sulfamate linkages.
  • Rosch Hannelore,DEX ; Frohlich Anja,DEX ; Ramalho-Ortigao Jose Flavio,DEX ; Montenarh Matthias,DEX ; Seliger Hartmut,DEX, Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages.
  • Wengel, Jesper; Nielsen, Poul, Oligonucleotide analogues.
  • Wengel, Jesper; Nielsen, Poul, Oligonucleotide analogues.
  • Weis Alexander Ludvik (Berwyn PA) Hausheer Frederick Herman (San Antonio TX) Chaturvedula Prasad Venkata Chala (Exton PA) Delecki Daniel Joseph (Radnor PA) Cavanaugh ; Jr. Paul Francis (West Chester , Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleo.
  • Simon Lionel N. ; Miller Paul S. ; Ts'o Paul O. P., Oligonucleotide analogues having improved stability at acid pH.
  • Priest John H. (Everett WA), Oligonucleotide conjugates.
  • Miyoshi Kenichi (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives.
  • Miyoshi Kenichi (Hiroshima JPX) Suzuki Masanori (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives.
  • Miyoshi Kenichi (Hiroshima JPX) Fuwa Toru (Hiroshima JPX), Oligonucleotide derivatives and production thereof.
  • Chaturvedula Prasad Venkata Chala (Exton PA), Oligonucleotide dimers with amide linkages replacing phosphodiester linkages.
  • Buhr Chris A. (Daly City CA), Oligonucleotide having enhanced binding affinity.
  • Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Worcester MA), Oligonucleotide multiple reporter precursors.
  • Dale Roderic M. K. ; Arrow Amy ; Srivastava Suresh C. ; Raza Syed K., Oligonucleotide phosphate esters.
  • Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  • Warren ; III Harold C. (Rush NY) Oakes Fred T. (Rochester NY), Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction proce.
  • Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide-folate conjugates.
  • Hornes Erik (Oslo NOX) Korsnes Lars (Oslo NOX), Oligonucleotide-linked magnetic particles and uses thereof.
  • Haralambidis Jim (Box Hill South AUX) Tregear Geoffrey W. (Hawthorn AUX), Oligonucleotide-polyamide conjugates and methods of production and applications of the same.
  • Manoharan, Muthiah, Oligonucleotides conjugated to protein-binding drugs.
  • Maag Hans (Menlo Park CA) Rose Samuel J. (Mountain View CA) Schmidt Beat (Baltschieder CHX), Oligonucleotides containing 4′-substituted nucleotides.
  • Gmeiner William H. (Omaha NE) Iversen Patrick L. (Omaha NE), Oligonucleotides containing 5-fluorouracil.
  • Froehler Brian (Belmont CA) Jones Robert J. (Daly City CA), Oligonucleotides containing 5-propynyl pyrimidines.
  • Cook Phillip D. (San Marcos CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), Oligonucleotides containing N-2 substituted purines.
  • Cook Phillip Dan (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purity.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity.
  • Cook Phillip Dan, Oligonucleotides having chiral phosphorus linkages.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Phillip Dan Cook ; Muthiah Manoharan, Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages.
  • Cook Alan Frederick, Oligonucleotides modified with conjugate groups.
  • Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA) Kaiser ; Jr. Robert J. (Glendale CA), Oligonucleotides possessing a primary amino group in the terminal nucleotide.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Oligonucleotides with cleavable sites.
  • Froehler Brian, Oligonucleotides with inverted polarity.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Lebleu Bernard (Montpellier FRX) Bayard Bernard (Castelnau Le Lez FRX), Oligonucleotides with modified phosphate and modified carbohydrate moieties at the respective chain termini.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Oligonucleotides with selectably cleavable and/or abasic sites.
  • Hoke Glenn (Mt. Airy MD) Cook Phillip D. (San Marcos CA), Oligonucleotides with substantially chirally pure phosphorothioate linkages.
  • Imbach Jean-Louis (Montpellier FRX) Gosselin Gilles J. M. (Montpellier FRX), Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon.
  • Jansz Hendrik S. (Zeist NLX) Lips Cornelis J. M. (The Hague NLX) Steenbergh Paul H. (Bunnik NLX) Rink Hans (Riehen CHX) Sieber Peter (Reinach CHX), Oligopeptides and intermediates and processes for their manufacture.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Shaw Barbara R. (Durham NC), Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Crooke Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  • Crooke Stanley T., Oligoribonucleotides for cleaving RNA.
  • Barascut Jean-Louis (Combaillaux FRX) Imbach Jean-Louis (Montpellier FRX), Oligothionucleotides.
  • McCall Maxine J.,AUX ; Hendry Philip,AUX ; Lockett Trevor,AUX, Optimized minizymes and miniribozymes and uses thereof.
  • Breipohl Gerhard,DEX ; Uhlmann Eugen,DEX, PNA synthesis using an amino protecting group which is labile to weak acids.
  • Cook Phillip Dan (Carlsbad CA), PNA-DNA-PNA chimeric macromolecules.
  • Torii Shigeru (Okayama-ken JPX) Tanaka Hideo (Okayama JPX) Taniguchi Masatoshi (Toyonaka JPX) Sasaoka Mitio (Tokushima-ken JPX) Shiroi Takashi (Tokushima-ken JPX) Kameyama Yutaka (Okayama JPX), Penam derivatives.
  • Meyer ; Jr. Rich B. (Woodinville WA) Gall Alexander A. (Bothell WA) Reed Michael W. (Seattle WA), Peptide linkers for improved oligonucleotide delivery.
  • Cook Phillip D. (Carlsbad CA) Kiely John (San Diego CA) Sprankle Kelly (Vista CA), Peptide nucleic acid combinatorial libraries and improved methods of synthesis.
  • Nielsen Peter E. (Hjortevanget 509 DK 2980 Kokkedal DKX) Buchardt Ole (Sondergardsvej 73 DK 3500 Vaerlose DKX) Egholm Michael (Johnstrup Alle 3 DK 1923 Frederiksberg DKX) Berg Rolf H. (Strandvaenget , Peptide nucleic acids.
  • Ole Buchardt DK; Michael Egholm DK; Peter Eigil Nielsen DK; Rolf Henrik Berg DK, Peptide nucleic acids.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; legal representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having amino acid side chains.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility.
  • Sullivan Sean (Boulder CO), Permeability enhancers for negatively charged polynucleotides.
  • Guzaev Andrei P. ; Manoharan Muthiah, Phosphate and thiophosphate protecting groups.
  • Tagawa Toshiaki (Yokohama JPX) Awane Kaoru (Yokohama JPX) Nagaike Kazuhiro (Sagamihara JPX), Phospholipid derivatized with PEG bifunctional linker and liposome containing it.
  • Peyman Anuschirwan,DEX ; Uhlmann Eugen,DEX ; Breipohl Gerhard,DEX ; Wallmeier Holger,DEX, Phosphonomonoester nucleic acids process for their preparation and their use.
  • Peyman Anuschirwan,DEX ; Uhlmann Eugen,DEX ; Breipohl Gerhard,DEX ; Wallmeier Holger,DEX, Phosphonomonoester nucleic acids, process for their preparation, and their use.
  • Caruthers Marvin H. (Boulder CO) Beaucage Serge L. (Boulder CO), Phosphoramidite compounds and processes.
  • Misiura Konrad (Lodz PLX) Gait Michael (Cambridge GB3), Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic.
  • Caruthers Marvin H. (Boulder CO) Beaucage Serge L. (Mountain View CA), Phosphoramidite nucleoside compounds.
  • Imbach Jean-Louis,FRX ; Rayner Bernard,FRX, Phosphorothioate triester oligonucleotides and method of preparation.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Photolabile reagents for incorporation into oligonucleotide chains.
  • Harris J. Milton (Huntsville AL) Kozlowski Antoni (Huntsville AL), Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives t.
  • Yamane Akio (Hiroshima JPX) Kawasoe Tatsuro (Hiroshima JPX) Tsukumo Noriko (Hiroshima JPX) Miyoshi Kenichi (Hiroshima JPX), Poly-labelled oligonucleotide derivative.
  • Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  • Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  • Zalipsky Samuel (Fremont CA) Martin Francis J. (San Francisco CA), Polymer compound and coated particle composition.
  • Bruice Thomas C. ; Dempcy Robert O. ; Almarsson Orn, Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages.
  • Maddry Joseph A. (Birmingham AL) Reynolds Robert C. (Birmingham AL) Secrist John A. (Birmingham AL) Montgomery John A. (Birmingham AL) Crooks Peter A. (Lexington KY), Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate.
  • Caruthers Marvin H. ; Brill Wolfgang K.-D,DEX ; Yau Eric ; Ma Michael ; Nielsen John,DKX, Polynucleotide phosphorodithioate compounds.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  • Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use.
  • Weeks Daniel L. ; Dagle John, Positively charged oligonucleotides as regulators of gene expression.
  • Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Preparation of oligodeoxyribonucleoside alkyl or arylphosphonates.
  • Just George,CAX ; Xin Zhili,CAX ; Marsault Eric,CAX ; Jin Yi,CAX, Preparation of phosphorothioate oligomers.
  • Caruthers Marvin H. (Boulder CO) Beaucage Serge L. (Mountain View CA), Process for oligonucleo tide synthesis using phosphormidite intermediates.
  • Bortolaso Roberto (Vicenza ITX) Stivanello Mariano (Vicenza ITX), Process for preparing [R-(R*,R*)]-5-(3-chlorophenyl)-3-[2-(3,4-dimethoxylphenyl)-1-methyl-ethyl]-oxazolidin-2-one.
  • Ravikumar Vasulinga T. (Carlsbad CA) Mulvey Dennis (Vista CA) Cole Douglas L. (San Diego CA) Cook Phillip D. (Carlsbad CA), Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Manoharan, Muthiah; Guzaev, Andrei P., Process for preparing peptide derivatized oligomeric compounds.
  • Caruthers Marvin H. (Boulder CO) Matteucci Mark D. (Boulder CO), Process for preparing polynucleotides.
  • Caruthers Marvin H. (Boulder CO) Matteucci Mark D. (Boulder CO), Process for preparing polynucleotides.
  • Rideout, Janet L.; Krenitsky, Thomas A., Process for producing deoxyribosides using bacterial phosphorylase.
  • Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Process for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cell.
  • McGee Daniel P. C. (Carlsbad CA), Process for the preparation of 2′-O-alkyl guanosine and related compounds.
  • McGee Daniel Peter Claude (Boulder CO), Process for the preparation of 2′-O-alkyl purine phosphoramidites.
  • Kster Hubert (Concord MA) Sinha Nanda D. (San Rafael CA), Process for the preparation of oligonucleotides.
  • Kster Hubert (Hamburg DEX) Sinha Nanda D. (Bundu Dt. Ranchi INX), Process for the preparation of oligonucleotides.
  • Cook Phillip Dan ; Springer Robert H. ; Sprankle Kelly G. ; Ross Bruce S., Process for the synthesis of 2'-O-substituted pyrimidines.
  • Cook Phillip Dan ; Springer Robert H. ; Sprankle Kelly G. ; Ross Bruce S., Process for the synthesis of 2'-O-substituted pyrimidines.
  • Cook Phillip Dan ; Sanghvi Yogesh S. ; Sprankle Kelly G. ; Ross Bruce S. ; Griffey Rich H. ; Springer Robert H., Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom.
  • Capaldi Daniel C. ; Ravikumar Vasulinga T., Process for the synthesis of oligomeric compounds.
  • Cheruvallath Zacharia S. ; Ravikumar Vasulinga T. ; Cole Douglas L., Process for the synthesis of oligomeric compounds.
  • Ravikumar Vasulinga T., Process for the synthesis of oligomeric compounds.
  • Vasulinga T. Ravikumar ; Muthiah Manoharan ; Daniel C. Capaldi ; Achim Krotz ; Douglas L. Cole ; Andrei Guzaev, Process for the synthesis of oligomeric compounds.
  • Weis Alexander L. (Berwyn PA) Saha Ashis K. (Frazer PA) Hausheer Frederick H. (San Antonio TX), Process of linking nucleosides with a siloxane bridge.
  • Manoharan Muthiah, Processes for the synthesis of oligomeric compounds.
  • Cheruvallath Zacharia S. ; Capaldi Daniel C. ; Ravikumar Vasulinga T. ; Cole Douglas L., Protecting group for synthesizing oligonucleotide analogs.
  • Beug Hartmut (Vienna ATX) Birnstiel Max L. (Vienna ATX) Cotten Matthew (Vienna ATX) Wagner Ernst (Langenzersdorf ATX), Protein-polycation conjugates.
  • Hawkins Mary E. (Potomac MD) Pfleiderer Wolfgang (Konstanz MD DEX) Davis Michael D. (Rockville MD) Balis Frank (Bethesda MD), Pteridine nucleotide analogs as fluorescent DNA probes.
  • Inoue Hideo (Sapporo JPX) Ohtsuka Eiko (Sapporo JPX) Imura Akihiro (Tokyo JPX) Masuda Kenichi (Hachioji JPX) Kamimura Takashi (Tokyo JPX), Pyridopyrimidine nucleotide compounds.
  • Matteucci Mark ; Jones Robert J. ; Lin Kuei-Ying, Pyrimidine derivatives.
  • Kuei-Ying Lin ; Mark D. Matteucci, Pyrimidine derivatives for labeled binding partners.
  • Lin Kuei-Ying ; Matteucci Mark D., Pyrimidine derivatives for labeled binding partners.
  • Matteucci Mark D. (Burlingame CA) Jones Robert J. (Millbrae CA) Lin Kuei-Ying (Fremont CA), Pyrimidine derivatives for labeled binding partners.
  • Matteucci Mark D. ; Jones Robert J., Pyrimidine derivatives for labeled binding partners.
  • Acevedo Oscar L. (San Diego CA) Hebert Normand (San Marcos CA), Pyrrolidine-containing monomers and oligomers.
  • Manoharan Muthiah ; Mohan Venkatraman ; Boswell Herb, RNA targeted 2'-modified oligonucleotides that are conformationally preorganized.
  • Hobbs ; Jr. Frank W. (Wilmington DE), Reagents for the preparation of 5′-tagged oligonucleotides.
  • Goodchild, John, Ribozymes having 2'-O substituted nucleotides in the flanking sequences.
  • Urdea Michael S. (Alamo CA), Ribozymes with product ejection by strand displacement.
  • Cantor Charles R. (Boston MA) Niemeyer Christof M. (Bremen DEX) Smith Cassandra L. (Boston MA) Sano Takeshi (Boston MA) Hnatowich Donald J. (Brookline MA) Rusckowski Mary (Southborough MA), Self-assembling multimeric nucleic acid constructs.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Ruth Jerry L. (San Diego CA), Single-stranded labelled oligonucleotides of preselected sequence.
  • Ruth Jerry L. (San Diego CA), Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis.
  • Agrawal, Sudhir; Tang, Jinyan, Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling.
  • Van Ness Jeffrey (Bothell WA) Petrie Charles R. (Woodinville WA) Tabone John C. (Bothell WA) Vermeulen Nicolaas M. J. (Woodinville WA), Solid supports for nucleic acid hybridization assays.
  • Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA), Solid tumor treatment method and composition.
  • Itakura Keiichi (Arcadia CA), Solid-phase synthesis of polynucleotides.
  • Itakura Keiichi (Arcadia CA), Solid-phase synthesis of polynucleotides.
  • Allen Theresa M. (Edmonton CA CAX) Martin Francis J. (San Francisco CA), Solid-tumor treatment method.
  • Gordon Julian (307 E. Sheridan Rd. Lake Bluft IL 60044) Minks Michael A. (Biochemistry Dept. ; University of the Witwatersrand ; 1 Jan Smuts Ave Johannesburg 2001 ZAX), Specific antibody to the native form of 2′5′-oligonucleotides, the method of preparation and the use as reagents in im.
  • Webb Murray S. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX) Mayer Lawrence D. (North Vancouver CAX), Sphingosomes for enhanced drug delivery.
  • Kool Eric T., Stem-loop oligonucleotides containing parallel and antiparallel binding domains.
  • Letsinger Robert L. (Wilmetter IL), Steroid modified oligonucleotides.
  • David Segev IL, Structural analogs of amine bases and nucleosides.
  • Khan Shaheer H. ; Menchen Steven M. ; Rosenblum Barnett B., Substituted propargylethoxyamido nucleosides, oligonucleotides and methods for using same.
  • Cook Phillip Dan (Carlsbad CA) Manoharan Muthiah (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA), Substituted purines and oligonucleotide cross-linking.
  • Wang Guangyi (Irvine CA) Ramasamy Kandasamy (Laguna Hills CA) Seifert Wilfried E. (La Jolla CA), Sugar modified nucleosides and oligonucleotides.
  • Cook Philip Dan ; Kawasaki Andrew M., Sugar modified oligonucleotides that detect and modulate gene expression.
  • Cook Phillip Dan (Carlsbad CA) Kawasaki Andrew Mamoro (Oceanside CA), Sugar modified oligonucleotides that detect and modulate gene expression.
  • Buendia Jean (Le Perreux Sur Marne FRX) Nierat Jeanine (Suresnes FRX), Supports and their use.
  • Cook P. Dan ; Acevedo Oscar L. ; Andrews Robert S., Synthesis of 3-deazapurines.
  • Kornberg Arthur (Portola Valley CA) Castuma Celina (Palo Alto CA), Synthetic liposomes for enhanced uptake and delivery.
  • Arnold ; Jr. Lyle John ; Hogrefe Richard Isais ; Reynolds Mark Alan ; Riley Timothy Andrew ; Schwartz David Aaron ; Vaghefi Morteza Monir ; Brown Bob Dale, Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages.
  • Dwyer Brian P. ; Arnold ; Jr. Lyle John ; Reynolds Mark Alan, Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate inter.
  • Sears Barry D. (Marblehead MA), Synthetic phospholipid compounds.
  • Sears Barry D. (Marblehead MA), Synthetic phospholipid compounds.
  • Manoharan, Muthiah, Targeted Oligonucleotide conjugates.
  • Manoharan Muthiah, Targeted oligonucleotide conjugates.
  • Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA), Texaphyrin compounds having improved functionalization.
  • Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA), Texaphyrin metal complexes having improved functionalization.
  • Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA) Kral Vladimir A. (Austin TX) Magda Darren (Cupertino CA), Texaphyrin-oligonucleotide conjugates.
  • Unger Evan C. (Tucson AZ) Fritz Thomas A. (Tucson AZ) Matsunaga Terry (Tucson AZ) Ramaswami VaradaRajan (Tucson AZ) Yellowhair David (Tucson AZ) Wu Guanli (Tucson AZ), Therapeutic drug delivery systems.
  • Cook Phillip D. (Carlsbad CA) Manoharan Muthiah (Carlsbad CA), Thiol-derivatized nucleosides.
  • Reed Michael W. (3575 NE. 180th Seattle WA 98105) Meyer ; Jr. Rich B. (15411 NE. 176th Pl. Woodinville WA 98072), Trifunctional intermediates for preparing 3′-tailed oligonucleotides.
  • Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages.
  • Summerton James (Corvallis OR) Weller Dwight (Corvallis OR) Stirchak Eugene (Corvallis OR), Uncharged polynucleotide-binding polymers.
  • Adrian Simmons GB; Clifford Smith GB, Use of LNA in mass spectrometry.
  • Walt F. Lima ; Stanley T. Crooke ; Muthiah Manoharan, Zinc finger peptide cleavage of nucleic acids.
  • McSwiggen,James A., siRNA treatment of diseases or conditions related to levels of IKK-gamma.
  • 이 특허를 인용한 특허 (15)

    1. Shimizu, Mamoru; Wada, Takeshi, Asymmetric auxiliary group.
    2. Shimizu, Mamoru; Wada, Takeshi, Asymmetric auxiliary group.
    3. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
    4. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
    5. Meena; Butler, David; Iwamoto, Naoki; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral design.
    6. Gemba, Takefumi, Chiral nucleic acid adjuvant.
    7. Gemba, Takefumi; Nagata, Ryoichi; Torikai, Yusuke, Chiral nucleic acid adjuvant having antitumor effect and antitumor agent.
    8. Gemba, Takefumi; Nagata, Ryoichi; Shiga, Ikumi, Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator.
    9. Rozners, Eriks; Zengeya, Thomas, Compositions and methods for recognition of RNA using triple helical peptide nucleic acids.
    10. Koller, Erich; Bennett, C. Frank, Compounds and methods for improving cellular uptake of oligomeric compounds.
    11. Koller, Erich; Bennett, C. Frank, Compounds and methods for improving cellular uptake of oligomeric compounds.
    12. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
    13. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
    14. Verdine, Gregory L.; Meena; Iwamoto, Naoki; Butler, David Charles Donnell, Methods for the synthesis of functionalized nucleic acids.
    15. Verdine, Gregory L.; ., Meena; Iwamoto, Naoki, Nucleic acid prodrugs and methods of use thereof.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로